D
KORU Medical Systems, Inc.
KRMD
$3.11
$0.134.36%
D
Sell
11/19/2024Upgraded
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 11/19/2024 due to a large increase in the total return index, growth index and solvency index. Operating cash flow increased 103.26% from -$346.7 to $11.3, earnings per share increased from -$0.0424 to -$0.0216, and EBIT increased 39.23% from -$1.96M to -$1.19M.
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 11/19/2024 due to a large increase in the total return index, growth index and solvency index. Operating cash flow increased 103.26% from -$346.7 to $11.3, earnings per share increased from -$0.0424 to -$0.0216, and EBIT increased 39.23% from -$1.96M to -$1.19M.
E
Sell
7/8/2024Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 7/8/2024 due to a decline in the volatility index.
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 7/8/2024 due to a decline in the volatility index.
D
Sell
6/21/2024Upgraded
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 6/21/2024 due to an increase in the total return index and volatility index.
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 6/21/2024 due to an increase in the total return index and volatility index.
E
Sell
5/3/2024Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 5/3/2024 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 3.49 to 3.19.
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 5/3/2024 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 3.49 to 3.19.
D
Sell
4/29/2024Upgraded
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
E
Sell
2/7/2024Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 2/7/2024 due to a decline in the volatility index, growth index and solvency index.
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 2/7/2024 due to a decline in the volatility index, growth index and solvency index.
D
Sell
1/23/2024Upgraded
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 1/23/2024 due to a noticeable increase in the growth index and valuation index. Earnings per share increased from -$0.0547 to -$0.03, EBIT increased 44.46% from -$3.22M to -$1.79M, and total revenue increased 0.97% from $6.94M to $7M.
KORU Medical Systems, Inc. (KRMD) was upgraded to D- from E+ on 1/23/2024 due to a noticeable increase in the growth index and valuation index. Earnings per share increased from -$0.0547 to -$0.03, EBIT increased 44.46% from -$3.22M to -$1.79M, and total revenue increased 0.97% from $6.94M to $7M.
E
Sell
7/5/2023Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 7/5/2023 due to a decline in the volatility index and solvency index.
KORU Medical Systems, Inc. (KRMD) was downgraded to E+ from D- on 7/5/2023 due to a decline in the volatility index and solvency index.
D
Sell
3/14/2023Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to D- from D on 3/14/2023 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.03 to -$0.0436, EBIT declined 28.73% from -$1.33M to -$1.71M, and the quick ratio declined from 3.6 to 3.15.
KORU Medical Systems, Inc. (KRMD) was downgraded to D- from D on 3/14/2023 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.03 to -$0.0436, EBIT declined 28.73% from -$1.33M to -$1.71M, and the quick ratio declined from 3.6 to 3.15.
D
Sell
2/23/2023Upgraded
KORU Medical Systems, Inc. (KRMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
KORU Medical Systems, Inc. (KRMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
KORU Medical Systems, Inc. (KRMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index and solvency index. Debt to equity increased from 0.01 to 0.03, and the quick ratio declined from 4.02 to 3.6.
KORU Medical Systems, Inc. (KRMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index and solvency index. Debt to equity increased from 0.01 to 0.03, and the quick ratio declined from 4.02 to 3.6.
D
Sell
5/5/2022Upgraded
Repro Med Systems, Inc. (KRMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and total return index.
Repro Med Systems, Inc. (KRMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index and total return index.
D
Sell
4/20/2022Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to D- from D on 4/20/2022 due to a decline in the solvency index. The quick ratio declined from 6.44 to 6.19.
Repro Med Systems, Inc. (KRMD) was downgraded to D- from D on 4/20/2022 due to a decline in the solvency index. The quick ratio declined from 6.44 to 6.19.
D
Sell
11/11/2021Upgraded
Repro Med Systems, Inc. (KRMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Earnings per share increased from -$0.03 to -$0.0247, and total revenue increased 9.27% from $5.53M to $6.04M.
Repro Med Systems, Inc. (KRMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Earnings per share increased from -$0.03 to -$0.0247, and total revenue increased 9.27% from $5.53M to $6.04M.
D
Sell
11/8/2021Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index, total return index and growth index. Total capital declined 1.46% from $37.99M to $37.43M.
Repro Med Systems, Inc. (KRMD) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index, total return index and growth index. Total capital declined 1.46% from $37.99M to $37.43M.
D
Sell
5/10/2021Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to D from D+ on 5/10/2021 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 434.91% from $249.2 to -$834.6, and total capital declined 9.5% from $40.22M to $36.4M.
Repro Med Systems, Inc. (KRMD) was downgraded to D from D+ on 5/10/2021 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 434.91% from $249.2 to -$834.6, and total capital declined 9.5% from $40.22M to $36.4M.
D
Sell
10/7/2020Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to D+ from C- on 10/7/2020 due to a major decline in the total return index and volatility index.
Repro Med Systems, Inc. (KRMD) was downgraded to D+ from C- on 10/7/2020 due to a major decline in the total return index and volatility index.
C
Hold
8/13/2020Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to C- from C on 8/13/2020 due to a substantial decline in the total return index and volatility index.
Repro Med Systems, Inc. (KRMD) was downgraded to C- from C on 8/13/2020 due to a substantial decline in the total return index and volatility index.
C
Hold
8/7/2020Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to C from B- on 8/7/2020 due to a significant decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.01 to -$0.03, and net income declined 339.43% from $449.4 to -$1.08M.
Repro Med Systems, Inc. (KRMD) was downgraded to C from B- on 8/7/2020 due to a significant decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.01 to -$0.03, and net income declined 339.43% from $449.4 to -$1.08M.
B
Buy
7/22/2020Upgraded
Repro Med Systems, Inc. (KRMD) was upgraded to B- from C+ on 7/22/2020 due to a noticeable increase in the total return index.
Repro Med Systems, Inc. (KRMD) was upgraded to B- from C+ on 7/22/2020 due to a noticeable increase in the total return index.
C
Hold
7/2/2020Downgrade
Repro Med Systems, Inc. (KRMD) was downgraded to C+ from B- on 7/2/2020 due to a substantial decline in the total return index.
Repro Med Systems, Inc. (KRMD) was downgraded to C+ from B- on 7/2/2020 due to a substantial decline in the total return index.
B
Buy
5/27/2020Upgraded
Repro Med Systems, Inc. (KRMD) was upgraded to B- from C+ on 5/27/2020 due to a large increase in the total return index and valuation index.
Repro Med Systems, Inc. (KRMD) was upgraded to B- from C+ on 5/27/2020 due to a large increase in the total return index and valuation index.
C
Hold
5/11/2020Upgraded
Repro Med Systems, Inc. (KRMD) was upgraded to C+ from C on 5/11/2020 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0097 to $0.01, and total revenue increased 1.73% from $6.22M to $6.33M.
Repro Med Systems, Inc. (KRMD) was upgraded to C+ from C on 5/11/2020 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0097 to $0.01, and total revenue increased 1.73% from $6.22M to $6.33M.
C
Hold
3/12/2019Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 3/12/2019 due to a major decline in the valuation index, growth index and total return index. Earnings per share declined from $0.01 to -$0.0099, operating cash flow declined 68.07% from $397.1 to $126.8, and EBIT declined 66.09% from $482.7 to $163.7.
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 3/12/2019 due to a major decline in the valuation index, growth index and total return index. Earnings per share declined from $0.01 to -$0.0099, operating cash flow declined 68.07% from $397.1 to $126.8, and EBIT declined 66.09% from $482.7 to $163.7.
C
Hold
2/20/2019Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 2/20/2019 due to a major decline in the total return index.
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 2/20/2019 due to a major decline in the total return index.
B
Buy
2/4/2019Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to B- from C+ on 2/4/2019 due to a noticeable increase in the total return index.
Repro Med Systems, Inc. (REPR) was upgraded to B- from C+ on 2/4/2019 due to a noticeable increase in the total return index.
C
Hold
1/18/2019Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 1/18/2019 due to a substantial decline in the growth index. Operating cash flow declined 59.02% from $968.9 to $397.1, and EBIT declined 21.77% from $617 to $482.7.
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 1/18/2019 due to a substantial decline in the growth index. Operating cash flow declined 59.02% from $968.9 to $397.1, and EBIT declined 21.77% from $617 to $482.7.
B
Buy
12/27/2018Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to B- from B on 12/27/2018 due to a decline in the total return index.
Repro Med Systems, Inc. (REPR) was downgraded to B- from B on 12/27/2018 due to a decline in the total return index.
B
Buy
10/15/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to B from B- on 10/15/2018 due to an increase in the total return index.
Repro Med Systems, Inc. (REPR) was upgraded to B from B- on 10/15/2018 due to an increase in the total return index.
B
Buy
9/27/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to B- from C+ on 9/27/2018 due to a substantial increase in the total return index.
Repro Med Systems, Inc. (REPR) was upgraded to B- from C+ on 9/27/2018 due to a substantial increase in the total return index.
C
Hold
9/12/2018Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 9/12/2018 due to a decline in the total return index, valuation index and volatility index.
Repro Med Systems, Inc. (REPR) was downgraded to C+ from B- on 9/12/2018 due to a decline in the total return index, valuation index and volatility index.
B
Buy
8/22/2018Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to B- from B on 8/22/2018 due to a substantial decline in the total return index and growth index.
Repro Med Systems, Inc. (REPR) was downgraded to B- from B on 8/22/2018 due to a substantial decline in the total return index and growth index.
B
Buy
8/7/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to B from C+ on 8/7/2018 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 7,496.18% from -$13.1 to $968.9, EBIT increased 23.13% from $501.1 to $617, and net income increased 17.92% from $403.4 to $475.7.
Repro Med Systems, Inc. (REPR) was upgraded to B from C+ on 8/7/2018 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 7,496.18% from -$13.1 to $968.9, EBIT increased 23.13% from $501.1 to $617, and net income increased 17.92% from $403.4 to $475.7.
C
Hold
8/2/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 8/2/2018 due to a major increase in the total return index and volatility index.
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 8/2/2018 due to a major increase in the total return index and volatility index.
C
Hold
6/22/2018Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 6/22/2018 due to a substantial decline in the total return index.
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 6/22/2018 due to a substantial decline in the total return index.
C
Hold
6/7/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 6/7/2018 due to a large increase in the total return index and valuation index.
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 6/7/2018 due to a large increase in the total return index and valuation index.
C
Hold
5/23/2018Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 5/23/2018 due to a large decline in the total return index and valuation index.
Repro Med Systems, Inc. (REPR) was downgraded to C from C+ on 5/23/2018 due to a large decline in the total return index and valuation index.
C
Hold
5/8/2018Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 5/8/2018 due to a significant increase in the total return index, efficiency index and volatility index. Total capital increased 5.86% from $7.67M to $8.12M.
Repro Med Systems, Inc. (REPR) was upgraded to C+ from C on 5/8/2018 due to a significant increase in the total return index, efficiency index and volatility index. Total capital increased 5.86% from $7.67M to $8.12M.
C
Hold
11/3/2017Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C from C- on 11/3/2017 due to a significant increase in the growth index, efficiency index and total return index. EBIT increased 106.2% from $190.3 to $392.4, earnings per share increased from $0.0039 to $0.007, and net income increased 78.99% from $148.5 to $265.8.
Repro Med Systems, Inc. (REPR) was upgraded to C from C- on 11/3/2017 due to a significant increase in the growth index, efficiency index and total return index. EBIT increased 106.2% from $190.3 to $392.4, earnings per share increased from $0.0039 to $0.007, and net income increased 78.99% from $148.5 to $265.8.
C
Hold
9/6/2017Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 9/6/2017 due to a noticeable increase in the total return index.
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 9/6/2017 due to a noticeable increase in the total return index.
D
Sell
8/22/2017Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 8/22/2017 due to a noticeable decline in the total return index and volatility index.
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 8/22/2017 due to a noticeable decline in the total return index and volatility index.
C
Hold
6/13/2017Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 6/13/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 6/13/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
D
Sell
2/6/2017Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 2/6/2017 due to a large decline in the total return index.
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 2/6/2017 due to a large decline in the total return index.
C
Hold
1/18/2017Upgraded
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 1/18/2017 due to a large increase in the total return index and volatility index.
Repro Med Systems, Inc. (REPR) was upgraded to C- from D+ on 1/18/2017 due to a large increase in the total return index and volatility index.
D
Sell
1/3/2017Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 1/3/2017 due to a noticeable decline in the efficiency index, growth index and total return index. Operating cash flow declined 215.09% from $346 to -$398.2, earnings per share declined from -$0.0022 to -$0.0028, and net income declined 26.27% from -$82.6 to -$104.3.
Repro Med Systems, Inc. (REPR) was downgraded to D+ from C- on 1/3/2017 due to a noticeable decline in the efficiency index, growth index and total return index. Operating cash flow declined 215.09% from $346 to -$398.2, earnings per share declined from -$0.0022 to -$0.0028, and net income declined 26.27% from -$82.6 to -$104.3.
C
Hold
12/6/2016Downgrade
Repro Med Systems, Inc. (REPR) was downgraded to C- from C on 12/6/2016 due to a significant decline in the valuation index, efficiency index and volatility index. Total capital declined 2% from $6.94M to $6.8M.
Repro Med Systems, Inc. (REPR) was downgraded to C- from C on 12/6/2016 due to a significant decline in the valuation index, efficiency index and volatility index. Total capital declined 2% from $6.94M to $6.8M.
D
Sell
7/1/2016Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C from C+ on 7/1/2016 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 5.25 to 4.4.
Repro-Med Systems Inc. (REPR) was downgraded to C from C+ on 7/1/2016 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 5.25 to 4.4.
C
Hold
5/13/2016Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to C+ from C on 5/13/2016 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 377.03% from $209.8 to $1M, earnings per share increased from $0.0044 to $0.0091, and net income increased 105.67% from $167.6 to $344.7.
Repro-Med Systems Inc. (REPR) was upgraded to C+ from C on 5/13/2016 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 377.03% from $209.8 to $1M, earnings per share increased from $0.0044 to $0.0091, and net income increased 105.67% from $167.6 to $344.7.
C
Hold
3/11/2016Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C from B on 3/11/2016 due to a significant decline in the volatility index.
Repro-Med Systems Inc. (REPR) was downgraded to C from B on 3/11/2016 due to a significant decline in the volatility index.
B
Buy
9/30/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B from C+ on 9/30/2015 due to a noticeable increase in the volatility index.
Repro-Med Systems Inc. (REPR) was upgraded to B from C+ on 9/30/2015 due to a noticeable increase in the volatility index.
C
Hold
9/25/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 9/25/2015 due to a decline in the volatility index and valuation index.
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 9/25/2015 due to a decline in the volatility index and valuation index.
B
Buy
9/23/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 9/23/2015 due to a decline in the volatility index.
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 9/23/2015 due to a decline in the volatility index.
B
Buy
9/8/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B from B- on 9/8/2015 due to an increase in the volatility index.
Repro-Med Systems Inc. (REPR) was upgraded to B from B- on 9/8/2015 due to an increase in the volatility index.
B
Buy
8/24/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 8/24/2015 due to a decline in the volatility index.
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 8/24/2015 due to a decline in the volatility index.
B
Buy
8/5/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B from B- on 8/5/2015 due to an increase in the volatility index and valuation index.
Repro-Med Systems Inc. (REPR) was upgraded to B from B- on 8/5/2015 due to an increase in the volatility index and valuation index.
B
Buy
7/21/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 7/21/2015 due to a noticeable decline in the volatility index and total return index.
Repro-Med Systems Inc. (REPR) was downgraded to B- from B on 7/21/2015 due to a noticeable decline in the volatility index and total return index.
B
Buy
7/10/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B from A- on 7/10/2015 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 121.58% from $299.4 to -$64.6, earnings per share declined from $0.0079 to -$0.0017, and operating cash flow declined 97.44% from $433.9 to $11.1.
Repro-Med Systems Inc. (REPR) was downgraded to B from A- on 7/10/2015 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 121.58% from $299.4 to -$64.6, earnings per share declined from $0.0079 to -$0.0017, and operating cash flow declined 97.44% from $433.9 to $11.1.
A
Buy
6/19/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 6/19/2015 due to an increase in the total return index.
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 6/19/2015 due to an increase in the total return index.
B
Buy
5/26/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 5/26/2015 due to a decline in the volatility index and valuation index.
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 5/26/2015 due to a decline in the volatility index and valuation index.
A
Buy
5/8/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 5/8/2015 due to a large increase in the growth index and solvency index. EBIT increased 236.9% from $134.4 to $452.8, earnings per share increased from $0.0024 to $0.0079, and operating cash flow increased 151.97% from $172.2 to $433.9.
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 5/8/2015 due to a large increase in the growth index and solvency index. EBIT increased 236.9% from $134.4 to $452.8, earnings per share increased from $0.0024 to $0.0079, and operating cash flow increased 151.97% from $172.2 to $433.9.
B
Buy
4/10/2015Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 4/10/2015 due to a major decline in the total return index and efficiency index. Net income declined 54.33% from $203 to $92.7.
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 4/10/2015 due to a major decline in the total return index and efficiency index. Net income declined 54.33% from $203 to $92.7.
A
Buy
1/12/2015Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 1/12/2015 due to a large increase in the total return index.
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 1/12/2015 due to a large increase in the total return index.
B
Buy
12/26/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 12/26/2014 due to a decline in the volatility index and valuation index.
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 12/26/2014 due to a decline in the volatility index and valuation index.
A
Buy
11/21/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 11/21/2014 due to an increase in the volatility index, total return index and solvency index.
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 11/21/2014 due to an increase in the volatility index, total return index and solvency index.
B
Buy
11/6/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 11/6/2014 due to a decline in the valuation index and volatility index.
Repro-Med Systems Inc. (REPR) was downgraded to B+ from A- on 11/6/2014 due to a decline in the valuation index and volatility index.
A
Buy
10/22/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 10/22/2014 due to an increase in the volatility index, total return index and valuation index.
Repro-Med Systems Inc. (REPR) was upgraded to A- from B+ on 10/22/2014 due to an increase in the volatility index, total return index and valuation index.
B
Buy
8/8/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B+ from B on 8/8/2014 due to a noticeable increase in the volatility index, valuation index and total return index.
Repro-Med Systems Inc. (REPR) was upgraded to B+ from B on 8/8/2014 due to a noticeable increase in the volatility index, valuation index and total return index.
B
Buy
7/16/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to B from B+ on 7/16/2014 due to a substantial decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.01 to $0.0043, EBIT declined 52.39% from $506.4 to $241.1, and the quick ratio declined from 5.48 to 4.05.
Repro-Med Systems Inc. (REPR) was downgraded to B from B+ on 7/16/2014 due to a substantial decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.01 to $0.0043, EBIT declined 52.39% from $506.4 to $241.1, and the quick ratio declined from 5.48 to 4.05.
B
Buy
7/7/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B+ from B on 7/7/2014 due to a substantial increase in the volatility index and total return index.
Repro-Med Systems Inc. (REPR) was upgraded to B+ from B on 7/7/2014 due to a substantial increase in the volatility index and total return index.
B
Buy
6/23/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B from C+ on 6/23/2014 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 251.43% from $101.1 to $355.3, earnings per share increased from $0.0044 to $0.01, and EBIT increased 110.47% from $240.6 to $506.4.
Repro-Med Systems Inc. (REPR) was upgraded to B from C+ on 6/23/2014 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 251.43% from $101.1 to $355.3, earnings per share increased from $0.0044 to $0.01, and EBIT increased 110.47% from $240.6 to $506.4.
C
Hold
5/20/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 5/20/2014 due to a decline in the total return index.
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 5/20/2014 due to a decline in the total return index.
B
Buy
5/5/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B- from C+ on 5/5/2014 due to an increase in the total return index.
Repro-Med Systems Inc. (REPR) was upgraded to B- from C+ on 5/5/2014 due to an increase in the total return index.
C
Hold
4/17/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 4/17/2014 due to a decline in the total return index.
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 4/17/2014 due to a decline in the total return index.
B
Buy
4/2/2014Upgraded
Repro-Med Systems Inc. (REPR) was upgraded to B- from C+ on 4/2/2014 due to an increase in the total return index.
Repro-Med Systems Inc. (REPR) was upgraded to B- from C+ on 4/2/2014 due to an increase in the total return index.
C
Hold
3/14/2014Downgrade
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 3/14/2014 due to a decline in the volatility index and total return index.
Repro-Med Systems Inc. (REPR) was downgraded to C+ from B- on 3/14/2014 due to a decline in the volatility index and total return index.
NASDAQ
03/11/2025 4:00PM Eastern
Quotes delayed
